Advertisement
U.S. markets close in 4 hours 3 minutes

Acura Pharmaceuticals, Inc. (ACUR)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00250.0000 (0.00%)
As of 10:36AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0025
Open0.0025
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0025 - 0.0025
52 Week Range0.0001 - 0.0500
Volume615
Avg. Volume1,066
Market Cap165,004
Beta (5Y Monthly)48.91
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ACUR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ACURA PHARMACEUTICALS INC
    Technical Assessment: Neutral in the Intermediate-TermWas that a case of quarter-end buying by institutions? Over the last 50 minutes of the trading session on Wednesday, the S&P 500 (SPX) took off like a rocket, surging 30 points and finishing 0.9% higher on the day and at another all-time high. But the biggest winners on the day were small-caps, with the Russell 2000 (IWM) surging 2.2% and the S&P 600 (SML) spiking 2.4%. The IWM is breaking out of a more-than two-year base and closed at its highest level since December 2021.
    Rating
    Fair Value
    Economic Moat
    5 hours agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.